New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer

Poly (ADP-ribose) polymerase (PARP) inhibitors are a therapeutic milestone exerting a synthetic lethal effect in the treatment of cancer involving BRCA1/2 mutation. Theoretically, PARP inhibitors (PARPi) eliminate tumor cells by disrupting DNA damage repair through either PARylation or the homologou...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ye, Yu, Xiaopeng, Li, Shuqiang, Tian, Ye, Liu, Caigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724080/
https://www.ncbi.nlm.nih.gov/pubmed/33324554
http://dx.doi.org/10.3389/fonc.2020.578095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724080/
https://www.ncbi.nlm.nih.gov/pubmed/33324554
http://dx.doi.org/10.3389/fonc.2020.578095

Ejemplares similares